Second, further studies have shown that overexpression of GLS2 during the latent period of epilepsy reduces susceptibility to chronic epilepsy, reduces epileptic activity according to behavioral tests, and reduces abnormal discharges in LFP recordings. The gene discussed is GLS2; the disease is epilepsy.